Chargement en cours...
The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase
OBJECTIVE: Hypercholesterolemia- (HC-) induced endothelial dysfunction is the first step of atherogenesis, and the peroxisome proliferator-activated receptor γ (PPARγ (PPARγ (PPARγ) has been reported to attenuate atherosclerosis formation; however, the underlying mechanisms are not fully understood....
Enregistré dans:
| Publié dans: | Cardiol Res Pract |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063881/ https://ncbi.nlm.nih.gov/pubmed/32190383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1845969 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|